A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Breast Cancer; Prostate Cancer; Colorectal Cancer; Thyroid Cancer; Breast Cancer Stage III; Breast Cancer Stage IV; Prostate Cancer Stage III; Prostate Cancer Stage IV; Colorectal Cancer Stage III; Colorectal Cancer Stage IV; Thyroid Cancer Stage III;...

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Hidradenitis Suppurativa Interventions: Drug: SAR445399; Drug: Placebo Sponsors: Sanofi Not yet recruiting Conditions: Hidradenitis Suppurativa Interventions: Drug: SAR445399; Drug: Placebo Sponsors: Sanofi Not yet...

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) – Relapsing-remitting Interventions: Drug: Ublituximab Sponsors: Northwestern University; TG Therapeutics, Inc. Not yet recruiting Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) –...

Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Spinal Cord Injury Cervical; Spinal Cord Injuries (Complete and Incomplete) Interventions: Device: Brain Computer Interface (BCI) – Functional Electrical Stimulation (FES) system Sponsors: Case Western Reserve University; University Hospitals...

A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Overweight; Obesity Interventions: Drug: LY4167586; Drug: Placebo; Drug: LY4167586 Sponsors: Eli Lilly and Company Not yet recruiting Conditions: Overweight; Obesity Interventions: Drug: LY4167586; Drug: Placebo; Drug: LY4167586 Sponsors: Eli Lilly and...